Inhibition of morphine-potentiated HIV-1 replication in peripheral blood mononuclear cells with the nuclease-resistant 2-5A agonist analog, 2-5AN6B

Journal of Acquired Immune Deficiency Syndromes

Volumn 30, Issue 1, 2002, Pages 9-20

  Homan, Joseph W ^a   Steele, Amber D ^a   Martinand Mari, Camille ^a   Rogers, Thomas J ^a   Henderson, Earl E ^a   Charubala, Ramamurthy ^a   Pfieiderer, Wolfgang ^a   Reichenbach, Nancy L ^a   Suhadolnik, Robert J ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

2 5A agonist; Chemokine; HIV 1; Interferon; Morphine; Peripheral blood mononuclear cells

Indexed keywords

2',5' OLIGOADENYLATE SYNTHETASE; ALPHA INTERFERON; CHEMOKINE; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; DOUBLE STRANDED RNA; GAMMA INTERFERON; MONOCYTE CHEMOTACTIC PROTEIN 1; MORPHINE; OPIATE; P68 KINASE; PHOSPHOTRANSFERASE; RANTES; RIBONUCLEASE; SAQUINAVIR; UNCLASSIFIED DRUG; VIRUS ENZYME; ZIDOVUDINE;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; LYMPHOCYTE; MONOCYTE; MONONUCLEAR CELL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS ADSORPTION; VIRUS REPLICATION;

EID: 0036570920     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-200205010-00002     Document Type: Article

References (66)

1. Mechanisms of morphine induced immunomodulation
2. Opiates and infection
3. Opioid peptides rapidly stimulate superoxide production by human polymorphonuclear leukocytes and macrophages
4. Immunomodulatory activity of - And -selective opioid agonists
5. Opiate receptor-mediated chemotaxis of human monocytes
6. Suppression of peritoneal macrophage phagocytosis of Candida albicans by opioids
7. Modulation of chemiluminescence in a murine macrophage cell line by neuroendocrine hormones
8. Dynorphin and related opioid peptides enhance tumoricidal activity mediated by murine peritoneal macrophages
9. Augmenting effect of opioid peptides on murine macrophage activation
10. Effect of morphine on resistance to infection
11. Lethality of morphine in mice infected with Toxoplasma gondii
12. The influence of morphine on development of HSV-1 and M-MSV virus infection in mice
13. Effects of morphine dependence on the pathogenesis of swine herpesvirus infection
14. Morphine promotes the growth of HIV-1 in human peripheral blood mononuclear cell cocultures
15. Effect of high doses of morphine on Con-A induced lymphokine production in vitro
16. Opioid-mediated suppression of interferon-production by cultured peripheral blood mononuclear cells
17. Regulation of RANTES chemokine gene expression requires cooperativity between NF-kappa B and IFN-regulatory factor transcription factors
18. IFN-gamma shapes immune invasion of the central nervous system via regulation of chemokines
19. Morphine induced alterations of immune status: Dose dependency, compartment specificity and antagonism by naltrexone
20. Morphine potentiates transforming growth factor-β release from human peripheral blood mononuclear cell cultures
21. Immunoregulatory effects of morphine on human lymphocytes
22. Effects of morphine on purified human blood monocytes: Modifications of properties involved in antiviral defenses
23. The interferon system: A bird's eye view of its biochemistry
24. Identification and characterization of an interferon (IFN)-stimulated response element-IFN-stimulated gene factor 3-independent signaling pathway for IFN-
25. Mechanism of interferon action: Characterization of the intermolecular autophosphorylation of PKR, the interferon-inducible, RNA-dependent protein kinase
26. Double-stranded RNA-activated protein kinase mediates virus-induced apoptosis: A new role for an old actor
27. Binding of tat protein to TAR region of human immunodeficiency virus type 1 blocks TAR-mediated activation of (2′-5′)oligoadenylate synthetase
28. Clinical, immunologic and virological effects of ampligen, a mismatched double-stranded RNA, in patients with AIDS or AIDS-related complex
29. Human immunodeficiency virus-1 tat protein binds TAR RNA in vitro
30. Modulation of nuclear matrix-associated 2′,5′-oligoadenylate, metabolism and ribonuclease L activity in H9 cells by human immunodeficiency virus
31. Inhibition of HIV-1 replication and activation of RNase L by phosphorothioate/phosphodiester 2′,5′-oligoadenylate derivatives
32. Synthesis and characterization of cordycepin-trimer-vitamin and -lipid conjugates. Potential inhibitors of HIV-1 replication
33. Synthesis and biologic activity of new base-modified (2′-5′)oligoadenylate trimers. Nucleotides 413. Part LII
34. Synthesis and biologic activity of (2′-5′)oligoadenylate trimers containing a 5′-terminal 5′-amino-5′-deoxy- or 5′-amino-3′,5′-dideoxyadenosine derivative
35. Altered HIV expression and EBV-induced transformation in coinfected PBLs
36. Opiates, human peripheral blood mononuclear cells, and HIV
37. Evidence for a novel low molecular weight RNase L in chronic fatigue syndrome
38. Phosphorothioate analogues of 2′,5′-oligoadenylate. Enzymatically synthesized 2′,5′-phosphorothioate dimer and trimer: Unequivocal structural assignment and activation of 2′,5′-oligoadenylate-dependent endoribonucleases
39. Cloning and characterization of a RNase L inhibitor. A new component of the interferon-regulated 2-5A pathway
40. Optimal conditions for the induction of human mononuclear leukocytes by complexed polyinosinic-polycytidylic acid
41. Recent advances in chemokines and chemokine receptors
42. Synthesis and properties of 3′-deoxyadenylate trimer dA2′p5′A2′p5′A
43. Core (2′-5′)oligoadenylate and the cordycepin analog: Inhibitors of Epstein-Barr virus-induced transformation of human lymphocytes in the absence of interferon
44. 6-Aminohexanoyl-linked conjugates of monomeric and trimer cordycepin
45. Inhibition of growth of estrogen receptor positive and estrogen receptor negative breast cancer cells in culture by AA-etherA, a stable 2-5A derivative
46. Survival with the acquired immunodeficiency syndrome: Experience with 5833 cases in New York City
47. Changes in T-lymphocyte subsets in intravenous drug users with HIV-1 infection
48. Prognostic indicators for development of AIDS among intravenous drug users
49. + lymphocytes in human immunodeficiency virus-positive homosexual men and injecting drug users
50. Differences in progression to AIDS between injection drug users and homosexual men with documented dates of seroconversion
51. Risk behavior and HIV infection among new drug injections in the era of AIDS in New York City
52. Correlates of HIV infection among young adult short-term injection drug users
53. Methadone enhances human immunodeficiency virus infection of human immune cells
54. Opiates as potential cofactors in progression of HIV-1 infections to AIDS
55. + decline among HIV-infected injecting drug users
56. Consequences of opiate dependency in a monkey model of AIDS
57. Modulation of simian AIDS by opioids
58. In vivo fate of HIV-1-infected T cells: Quantitative analysis of the transition to stable latency
59. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy
60. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia
61. Inhibition of human immunodeficiency virus (HIV-1) replication in SupT1 cells transduced with a HIV-1 LTR-driven PKR cDNA construct
62. Inhibition of replication of reactivated human immunodeficiency virus type 1 in latently-infected U1 cells transduced with an HIV-1 LTR-driven PKR cDNA construct